Share DSM now in terms of PE among most expensive chemical companies

The Dutch stock DSM trades currently with one the highest CAPE-ratios of the chemical companies. Currently the share is now traded at 29 times the past 10 year's average earnings per share. With this the stock trades way higher than the average US stock of the chemical companies which now costs 5 times the average 10-years EPS.

Core figures US chemical companies

financial analysis

We further see that over the past year the American chemical companies yielded 24 percent higher. They performed better than the European sector that yielded 24 percent higher. The American sector trades with a CAPE-ratio of 21 and the European sector trades at 102. The CAPE-ratios level doesn't seemt to have a relation with the price returns as the higher returns don't all have higher CAPE-ratios.

Over the current book year the total revenue will be 8,94 billion euros (consensus estimates). This is slightly lower than 2018's revenue of 9,01 billion euros.

Historical revenues and results DSM plus estimates 2020


The analysts expect for 2020 a net profit of 786 million euros. For this year most of the analysts expect a profit per share of 4,61 euros. So the price/earnings-ratio equals 25,29.

For this year most of the analysts expect a dividend of 2,46 euros per share. DSM's dividend yield thus equals 2,11 percent. The average dividend yield of the chemical companies equals an attractive 2,56 percent.

Newest target prices around 113 euros

The most recent recommendations for the chemical company are from JP Morgan, Morgan Stanley and Berenberg.

DSM's market capitalization is around 20,48 billion euros. The DSM stock was the past 12 months quite unstable. Since last June the stock is 14 percent higher. This year the stock price moved between 82 and 121 euro. Since 2008 the stock price is almost 253 percent higher.

Historical stock prices DSM

stock dsm

Click here for dividend DSM. At 14.12 the stock trades 1,42 percent lower at 116,6 euros. Nieuwsdienst: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.